Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-13

Clinical Trial Update: Evaluation of Civamide Patch in Treatment of Postherpetic Neuralgia and Post-Incisional Neuralgia [Phase 2]

View source ↗

Summary

An update on a Phase 2 clinical trial evaluating a civamide patch for treatment of postherpetic neuralgia and post-incisional neuralgia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Civamide Patch

Snippet

Sponsor: Winston Laboratories | Conditions: Postherpetic Neuralgia | Phase 2 | Status: COMPLETED